4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) Stock Information | RedChip

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)


$8.1400
-0.0600 ( -0.73% ) 42.2K

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Market Data


Open


$8.1400

Previous close


$8.2000

Volume


42.2K

Market cap


$426.15M

Day range


$8.0600 - $8.4100

52 week range


$7.9000 - $36.2500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Sep 18, 2024
4 Insider transactions 1 Sep 18, 2024
4 Insider transactions 1 Aug 21, 2024
8-k 8K-related 13 Aug 08, 2024
10-q Quarterly Reports 90 Aug 08, 2024
3 Insider transactions 1 Aug 01, 2024
8-k 8K-related 13 Jul 23, 2024
4 Insider transactions 1 Jul 18, 2024
8-k 8K-related 13 Jul 17, 2024
4 Insider transactions 1 Jul 15, 2024

Latest News